Search Results

The Roche UNIMATE HDL Direct reagent is an in vitro diagnostic device intended for use in clinical and physician's office laboratories (POL) on COBAS MIRA systems for the quantitative determination of High Density Lipoprotein Cholesterol (HDL CHOL) in serum.

The Roche UNIMATE HDL Direct reagent is an in vitro diagnostic test for the quantitative determination of High Density Lipoprotein Cholesterol (HDL CHOL) in serum. UNIMATE HDL Direct is intended for use in clinical and physician's office laboratories (POL) on COBAS MIRA systems. Determination of HDL cholesterol is useful for early detection of an increased risk of atherosclerosis. The principle of the Roche UNIMATE HDL Direct reagent is based on the absorbance of synthetic polymers and polyanions to the surface of lipoproteins. LDL, VLDL, and chylomicrons are transformed into a detergent-resistant form, whereas HDL is not. Combined actions of polymers, polyanions and detergent solubilizes cholesterol from HDL, but not from LDL, VLDL, and chylomicrons. Solubilized cholesterol is oxidized by the sequential enzymatic action of cholesterol esterase and cholesterol oxidase. The H,O, produced in this reaction is reacted with chromogens to form a colored dye. The increase in absorbance at 550 nm is directly proportional to the HDL cholesterol concentration of the sample.

The document describes the Roche UNIMATE HDL Direct reagent, an in vitro diagnostic test for the quantitative determination of High Density Lipoprotein Cholesterol (HDL CHOL) in serum, specifically for use in physician's office laboratories (POLs).

Here's an analysis of the acceptance criteria and the study that proves the device meets them:

1. Table of Acceptance Criteria and Reported Device Performance:

The document doesn't explicitly state "acceptance criteria" in a single consolidated table. However, it implicitly uses the National Cholesterol Education Program (NCEP) goals for precision as an acceptance criterion for within-run and total precision, and correlation coefficients for agreement between methods.

2. Sample Size Used for the Test Set and the Data Provenance:

• Sample Size for Test Set:
  • Site #1: 50 split samples
  • Site #2: 59 split samples
  • Site #3: 65 split samples
• Data Provenance: The data was collected from three different physician office laboratories (POLs). These were "split samples," meaning aliquots of each sample were also tested in-house at Roche Diagnostics Systems' (RDS) laboratory to establish a reference site. This suggests the data is prospective, as it was collected specifically for this study. The country of origin is not explicitly stated, but given the sponsor's location (New Jersey, USA) and FDA submission, it's highly likely to be USA.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts:

The concept of "experts" establishing ground truth in the traditional sense (e.g., radiologists interpreting images) is not directly applicable here. The "ground truth" or reference in this context is established by:

• Roche Diagnostics Systems' (RDS) laboratory using the Roche UNIMATE HDL Direct reagent, serving as a reference for comparison with POL results. The qualifications of the personnel performing these tests are not specified, but it's assumed they are skilled laboratory technicians following standardized protocols.
• The POL's "usual method" for HDL cholesterol determination served as another comparator, representing current practice.

4. Adjudication Method for the Test Set:

No explicit adjudication method (like 2+1, 3+1) is mentioned for the test set. The study compares results from:

1. POLs using Roche UNIMATE HDL Direct vs. RDS reference lab using Roche UNIMATE HDL Direct.
2. POLs using their usual methodology vs. POLs using Roche UNIMATE HDL Direct.

This is a direct comparison study between methods rather than an adjudication process to determine a single "truth."

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance:

This is not an MRMC comparative effectiveness study in the context of human readers/interpreters and AI. This study evaluates an in vitro diagnostic reagent (a chemical test) and its performance compared to other methods and a reference laboratory. Therefore, the concept of "human readers improving with AI" is not relevant here.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done:

The Roche UNIMATE HDL Direct reagent is an automated chemical assay designed for use on COBAS MIRA systems. It operates in a standalone manner in that once the sample is loaded and the instrument is running, the determination of HDL cholesterol concentration is performed by the reagent and instrumentation without direct human intervention in the result generation process for that specific test run. The results are then read and interpreted by laboratory personnel. So, yes, it performs as a standalone assay in its operation.

7. The Type of Ground Truth Used (expert consensus, pathology, outcomes data, etc.):

The "ground truth" for the test set is established by two primary mechanisms:

• Reference Laboratory Results: The results obtained by Roche Diagnostics Systems' (RDS) laboratory using the Roche UNIMATE HDL Direct reagent served as a highly controlled and standardized reference for evaluating the performance of the POL sites using the same reagent.
• National Reference System for Cholesterol: For the broader context of method traceability, the device was compared directly to the cholesterol "reference method" (though not detailed here) that is traceable to the National Reference System for Cholesterol and covers NCEP medical decision points. This implies an established and validated reference standard for cholesterol measurement.

8. The Sample Size for the Training Set:

The document does not specify a separate "training set" or its size. This is a performance study for an in vitro diagnostic reagent, not a machine learning algorithm that typically requires training data. The study describes experiments to validate the reagent's performance in different settings.

9. How the Ground Truth for the Training Set Was Established:

As there is no "training set" in the context of a machine learning algorithm, this question is not applicable. The performance studies involved comparing the device's results against established methods and a reference laboratory to demonstrate substantial equivalence, not to "train" the device.

Ask a specific question about this device